Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B

<b>Abstract: </b>Virus-like vesicles (VLV) are hybrid vectors based on an evolved Semliki Forest virus (SFV) RNA replicon and the envelope glycoprotein (G) from vesicular stomatitis virus (VSV) [...]

Bibliographic Details
Main Authors: Carolina Chiale, Timur O. Yarovinsky, Stephen W. Mason, Bhaskara R. Madina, Manisha Menon, Marie M. Krady, Safiehkhatoon Moshkani, Anasuya Chattopadhyay Pal, Bijan Almassian, John K. Rose, Michael D. Robek, Valerian Nakaar
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Vaccines
Subjects:
n/a
Online Access:https://www.mdpi.com/2076-393X/8/2/279
id doaj-efdc067d90fc45c5b1ca5f61f0988c53
record_format Article
spelling doaj-efdc067d90fc45c5b1ca5f61f0988c532020-11-25T02:26:46ZengMDPI AGVaccines2076-393X2020-06-01827927910.3390/vaccines8020279Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis BCarolina Chiale0Timur O. Yarovinsky1Stephen W. Mason2Bhaskara R. Madina3Manisha Menon4Marie M. Krady5Safiehkhatoon Moshkani6Anasuya Chattopadhyay Pal7Bijan Almassian8John K. Rose9Michael D. Robek10Valerian Nakaar11Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USADepartment of Pathology, Yale University School of Medicine, New Haven, CT 06510, USACaroGen Corporation, Farmington, CT 06032, USACaroGen Corporation, Farmington, CT 06032, USACaroGen Corporation, Farmington, CT 06032, USACaroGen Corporation, Farmington, CT 06032, USADepartment of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USADepartment of Pathology, Yale University School of Medicine, New Haven, CT 06510, USACaroGen Corporation, Farmington, CT 06032, USADepartment of Pathology, Yale University School of Medicine, New Haven, CT 06510, USADepartment of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USACaroGen Corporation, Farmington, CT 06032, USA<b>Abstract: </b>Virus-like vesicles (VLV) are hybrid vectors based on an evolved Semliki Forest virus (SFV) RNA replicon and the envelope glycoprotein (G) from vesicular stomatitis virus (VSV) [...]https://www.mdpi.com/2076-393X/8/2/279n/a
collection DOAJ
language English
format Article
sources DOAJ
author Carolina Chiale
Timur O. Yarovinsky
Stephen W. Mason
Bhaskara R. Madina
Manisha Menon
Marie M. Krady
Safiehkhatoon Moshkani
Anasuya Chattopadhyay Pal
Bijan Almassian
John K. Rose
Michael D. Robek
Valerian Nakaar
spellingShingle Carolina Chiale
Timur O. Yarovinsky
Stephen W. Mason
Bhaskara R. Madina
Manisha Menon
Marie M. Krady
Safiehkhatoon Moshkani
Anasuya Chattopadhyay Pal
Bijan Almassian
John K. Rose
Michael D. Robek
Valerian Nakaar
Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B
Vaccines
n/a
author_facet Carolina Chiale
Timur O. Yarovinsky
Stephen W. Mason
Bhaskara R. Madina
Manisha Menon
Marie M. Krady
Safiehkhatoon Moshkani
Anasuya Chattopadhyay Pal
Bijan Almassian
John K. Rose
Michael D. Robek
Valerian Nakaar
author_sort Carolina Chiale
title Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B
title_short Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B
title_full Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B
title_fullStr Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B
title_full_unstemmed Modified Alphavirus-Vesiculovirus Hybrid Vaccine Vectors for Homologous Prime-Boost Immunotherapy of Chronic Hepatitis B
title_sort modified alphavirus-vesiculovirus hybrid vaccine vectors for homologous prime-boost immunotherapy of chronic hepatitis b
publisher MDPI AG
series Vaccines
issn 2076-393X
publishDate 2020-06-01
description <b>Abstract: </b>Virus-like vesicles (VLV) are hybrid vectors based on an evolved Semliki Forest virus (SFV) RNA replicon and the envelope glycoprotein (G) from vesicular stomatitis virus (VSV) [...]
topic n/a
url https://www.mdpi.com/2076-393X/8/2/279
work_keys_str_mv AT carolinachiale modifiedalphavirusvesiculovirushybridvaccinevectorsforhomologousprimeboostimmunotherapyofchronichepatitisb
AT timuroyarovinsky modifiedalphavirusvesiculovirushybridvaccinevectorsforhomologousprimeboostimmunotherapyofchronichepatitisb
AT stephenwmason modifiedalphavirusvesiculovirushybridvaccinevectorsforhomologousprimeboostimmunotherapyofchronichepatitisb
AT bhaskararmadina modifiedalphavirusvesiculovirushybridvaccinevectorsforhomologousprimeboostimmunotherapyofchronichepatitisb
AT manishamenon modifiedalphavirusvesiculovirushybridvaccinevectorsforhomologousprimeboostimmunotherapyofchronichepatitisb
AT mariemkrady modifiedalphavirusvesiculovirushybridvaccinevectorsforhomologousprimeboostimmunotherapyofchronichepatitisb
AT safiehkhatoonmoshkani modifiedalphavirusvesiculovirushybridvaccinevectorsforhomologousprimeboostimmunotherapyofchronichepatitisb
AT anasuyachattopadhyaypal modifiedalphavirusvesiculovirushybridvaccinevectorsforhomologousprimeboostimmunotherapyofchronichepatitisb
AT bijanalmassian modifiedalphavirusvesiculovirushybridvaccinevectorsforhomologousprimeboostimmunotherapyofchronichepatitisb
AT johnkrose modifiedalphavirusvesiculovirushybridvaccinevectorsforhomologousprimeboostimmunotherapyofchronichepatitisb
AT michaeldrobek modifiedalphavirusvesiculovirushybridvaccinevectorsforhomologousprimeboostimmunotherapyofchronichepatitisb
AT valeriannakaar modifiedalphavirusvesiculovirushybridvaccinevectorsforhomologousprimeboostimmunotherapyofchronichepatitisb
_version_ 1724845848111611904